Table II.
Correlation of vimentin at the invasive front with various clinical and histopathological parameters and the risk score
| Vimentin (IF) | Positive (n=8), n (%) | Negative (n=22), n (%) |
|---|---|---|
| Gender | ||
| Male | 6 (30) | 14 (70) |
| Female | 2 (20) | 8 (80) |
| Differentiation of tumour | ||
| WDSCC | 2 (20) | 8 (80) |
| MDSCC | 5 (26.3) | 14 (73.7) |
| PDSCC | 1 (100) | 0 |
| TNM stage | ||
| I/II | 5 (27.7) | 13 (72.3) |
| III/IV | 3 (25) | 9 (75) |
| Tumour size (cm) | ||
| ≤4 | 8 (28.5) | 20 (71.5) |
| >4 | 0 | 2 (100) |
| Depth of invasion (mm) | ||
| <4 | 2 (20) | 8 (80) |
| ≥4 | 6 (30) | 14 (70) |
| Lymph node status | ||
| Positive | 3 (27.2) | 8 (72.8) |
| Negative | 5 (26.3) | 14 (73.7) |
| POI | ||
| POI (1/2/3) | 4 (25) | 12 (75) |
| POI 4 | 4 (28.5) | 10 (71.5) |
| PNI | ||
| Present | 3 (18.7) | 13 (81.3) |
| Absent | 5 (35.7) | 9 (64.3) |
| LI | ||
| LI-1 | 5 (29.4) | 12 (70.6) |
| LI-2 | 3 (27.2) | 8 (72.8) |
| LI-3 | 0 | 2 (100) |
| Risk score | ||
| Low | 2 (40) | 3 (60) |
| Intermediate | 3 (20) | 12 (80) |
| High | 3 (30) | 7 (70) |
POI, pattern of invasion; PNI, perineural invasion; LI, lymphocytic infiltrate